Catnip

Catnip contains nepetalactone, which acts as a mild CNS depressant in humans via GABAergic pathway modulation. Ethanol extracts of Nepeta cataria demonstrate CNS-depressant activity comparable to diazepam in mouse models. Co-administration produces additive sedation, drowsiness, and potentially impaired coordination.

Advise patients on benzodiazepines to avoid or use only small amounts of catnip preparations. Warn against driving or operating machinery when combining. Do not co-administer for prolonged periods without clinician supervision.

Nepetalactone exhibits sedative activity through CNS depressant/GABAergic mechanisms. Combining catnip with Z-drugs produces additive hypnotic and sedative effects that may prolong next-day drowsiness, increase falls risk (especially in elderly), and impair psychomotor function.

Counsel patients using prescription sleep medications to avoid catnip tea before bedtime or concurrent use. If a patient wishes to use catnip, consider reducing the Z-drug dose under clinician supervision. Warn about fall risk and morning impairment.

Catnip's nepetalactone modulates CNS activity producing sedation. Combined with barbiturates there is additive CNS and respiratory depression. Notably, in mice, acute catnip administration paradoxically decreased sleeping time after sodium pentobarbital, suggesting complex pharmacokinetic interactions; long-term exposure increased susceptibility to seizures induced by GABA antagonists.

Avoid concurrent use of catnip with barbiturate sedatives. The interaction is unpredictable (may either potentiate sedation or alter barbiturate disposition). Patients on phenobarbital for seizure disorders should avoid catnip to prevent seizure breakthrough risk.

Catnip has mild diuretic effects. Lithium is renally excreted and its clearance is highly sensitive to changes in fluid/sodium balance. Reduced lithium excretion due to diuresis-induced volume depletion can raise serum lithium levels into the toxic range (tremor, confusion, ataxia, seizures).

Patients on lithium should avoid catnip tea or supplements. If already using, monitor serum lithium levels more frequently and watch for signs of toxicity. Counsel about maintaining hydration.

Catnip's CNS-depressant action via nepetalactone adds to ethanol's GABAergic depression, producing exaggerated sedation, impaired coordination, poor judgment, and risk of falls or accidents.

Advise patients using catnip (especially for sleep) to avoid alcohol. Do not combine catnip tea or tinctures with alcoholic beverages or other sedating agents such as antihistamines.